Protalix BioTherapeutics (PLX)
Protalix BioTherapeutics Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 3.728M | -4.928M | 1.132M | 0.764M | 6.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | 1.32M | 0.395M | 0.22M | 0.132M | 0.778M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 2.408M | -5.323M | 0.912M | 0.632M | 5.222M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 8.847M | 10.60M | 9.34M | 7.319M | 10.56M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 1.629M | 1.617M | 1.526M | 1.799M | 1.989M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | 2.003M | 8.678M | 1.187M | -5.382M | 2.292M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Operating Expenses | 9.793M | 3.93M | 9.899M | 14.63M | 11.04M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -6.065M | -8.858M | -8.767M | -13.87M | -5.038M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | 0.161M | -0.055M | -0.108M | 0.179M | -0.014M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -5.904M | -8.913M | -8.875M | -13.69M | -5.052M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income after Tax | -5.904M | -8.913M | -8.875M | -13.69M | -5.052M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -5.904M | -8.913M | -8.875M | -13.69M | -5.052M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -5.904M | -8.913M | -8.875M | -13.69M | -5.052M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 87.82 | 84.64 | 85.59 | 85.58 | 81.74 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 87.82 | 84.64 | 85.59 | 85.58 | 81.74 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.07 | -0.11 | -0.10 | -0.16 | -0.06 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.07 | -0.11 | -0.10 | -0.16 | -0.06 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
